首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Dynamic Modulation of Innate Immune Response by Varying Dosages of Lipopolysaccharide (LPS) in Human Monocytic Cells
【2h】

Dynamic Modulation of Innate Immune Response by Varying Dosages of Lipopolysaccharide (LPS) in Human Monocytic Cells

机译:动态调节人单核细胞中脂多糖(LPS)剂量的先天免疫反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Innate monocytes and macrophages can be dynamically programmed into distinct states depending upon the strength of external stimuli. Innate programming may bear significant relevance to the pathogenesis and resolution of human inflammatory diseases. However, systems analyses with regard to the dynamic programming of innate leukocytes are lacking. In this study, we focused on the dynamic responses of human promonocytic THP-1 cells to lipopolysaccharide (LPS). We observed that varying dosages of LPS differentially modulate the expression of selected pro- and anti- inflammatory mediators such as IL-6 and IL-33. Super-low dosages of LPS preferentially induced the pro-inflammatory mediator IL-6, while higher dosages of LPS induced both IL-6 and IL-33. Mechanistically, we demonstrated that super-low and high doses of LPS cause differential activation of GSK3 and Akt, as well as the transcription factors FoxO1 and CREB. Inhibition of GSK3 enabled THP-1 cells to express IL-33 when challenged with super-low dose LPS. On the other hand, activation of CREB with adenosine suppressed IL-6 expression. Taken together, our study reveals a dynamic modulation of monocytic cells in response to varying dosages of endotoxin, and may shed light on our understanding of the dynamic balance that controls pathogenesis and resolution of inflammatory diseases.
机译:先天性单核细胞和巨噬细胞可以根据外部刺激的强度动态编程为不同的状态。先天性程序设计可能与人类炎性疾病的发病机理和消退息息相关。但是,缺乏关于先天性白细胞的动态编程的系统分析。在这项研究中,我们专注于人类单核细胞THP-1细胞对脂多糖(LPS)的动态响应。我们观察到,不同剂量的LPS会差异性地调节选定的促炎介质和消炎介质(例如IL-6和IL-33)的表达。 LPS的超低剂量优先诱导促炎性介质IL-6,而LPS的较高剂量则诱导IL-6和IL-33。从机制上讲,我们证明了超低剂量和高剂量的LPS会引起GSK3和Akt以及转录因子FoxO1和CREB的差异激活。当受到超低剂量LPS​​攻击时,GSK3的抑制使THP-1细胞表达IL-33。另一方面,用腺苷活化CREB抑制了IL-6表达。综上所述,我们的研究揭示了对内毒素剂量的变化作出反应的单核细胞的动态调节,并且可能有助于我们了解控制炎症性疾病的发病机制和消退的动态平衡。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号